Leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because its clear it isnt helping. Results released Friday from 1,542 patients showed the drug did not reduce deaths, time in the hospital or other factors. The results convincingly rule out any meaningful mortality benefit, study leaders at the University of Oxford said in a statement. The Oxford study is the largest study so far to put hydroxychloroquine to a strict test. The World Health Organization is leading a similar study testing hydroxychloroquine and several other therapies versus standard of care.

WASHINGTON, D.C. – Ousted vaccine specialist Rick Bright, Ph.D., is making more bombshell comments as he prepares to testify before Congress Thursday. Bright has already claimed he was retaliated against for recommending against the use of Hydroxychloroquine, a malaria drug pushed by the President Trump. Trumps has said he does not know of Bright, one of the Trump Administration's top researchers. Model predicts jump in deathsMeanwhile, as 45 states are easing restrictions to re-open, a new model used by the White House is now showing 147,000 COVID-19 deaths by August. From the safety of the White House where testing is available every day, Trump's son-in-law, Jared Kushner, dismissed the warnings.